Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci

[1]  Kali T. Witherspoon,et al.  Excess of rare, inherited truncating mutations in autism , 2015, Nature Genetics.

[2]  Stephan J Sanders,et al.  The autism-associated chromatin modifier CHD8 regulates other autism risk genes during human neurodevelopment , 2015, Nature Communications.

[3]  Cathleen K. Yoshida,et al.  Increased female autosomal burden of rare copy number variants in human populations and in autism families , 2015, Molecular Psychiatry.

[4]  Stephan J. Sanders,et al.  Genotype to phenotype relationships in autism spectrum disorders , 2014, Nature Neuroscience.

[5]  Tomas W. Fitzgerald,et al.  Large-scale discovery of novel genetic causes of developmental disorders , 2014, Nature.

[6]  Michael Snyder,et al.  Integrated systems analysis reveals a molecular network underlying autism spectrum disorders , 2014, Molecular systems biology.

[7]  Boris Yamrom,et al.  The contribution of de novo coding mutations to autism spectrum disorder , 2014, Nature.

[8]  Christopher S. Poultney,et al.  Synaptic, transcriptional, and chromatin genes disrupted in autism , 2014, Nature.

[9]  Kali T. Witherspoon,et al.  Recurrent de novo mutations implicate novel genes underlying simplex autism risk , 2014, Nature Communications.

[10]  Kathryn Roeder,et al.  De novo insertions and deletions of predominantly paternal origin are associated with autism spectrum disorder. , 2014, Cell reports.

[11]  Manolis Kellis,et al.  CHD8 regulates neurodevelopmental pathways associated with autism spectrum disorder in neural progenitors , 2014, Proceedings of the National Academy of Sciences.

[12]  M. Daly,et al.  Autism spectrum disorder severity reflects the average contribution of de novo and familial influences , 2014, Proceedings of the National Academy of Sciences.

[13]  Kali T. Witherspoon,et al.  Refining analyses of copy number variation identifies specific genes associated with developmental delay , 2014, Nature Genetics.

[14]  Elodie Ey,et al.  Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments , 2014, PLoS genetics.

[15]  Stephan J Sanders,et al.  A framework for the interpretation of de novo mutation in human disease , 2014, Nature Genetics.

[16]  Stephan J Sanders,et al.  Cross-Disorder Comparison of Four Neuropsychiatric CNV Loci , 2014, Current Genetic Medicine Reports.

[17]  M C O'Donovan,et al.  Copy number variation in schizophrenia in Sweden , 2014, Molecular Psychiatry.

[18]  Stephen J. Guter,et al.  Convergence of Genes and Cellular Pathways Dysregulated in Autism Spectrum Disorders , 2014, American journal of human genetics.

[19]  Sven Bergmann,et al.  A higher mutational burden in females supports a "female protective model" in neurodevelopmental disorders. , 2014, American journal of human genetics.

[20]  Kathryn Roeder,et al.  DAWN: a framework to identify autism genes and subnetworks using gene expression and genetics , 2014, Molecular Autism.

[21]  J. Gusella,et al.  Disruption of MBD5 contributes to a spectrum of psychopathology and neurodevelopmental abnormalities , 2014, Molecular Psychiatry.

[22]  Katrina Tatton-Brown,et al.  Mutations in the DNA methyltransferase gene, DNMT3A, cause an overgrowth syndrome with intellectual disability , 2014, Nature Genetics.

[23]  R. McPherson.  Genome-Wide Association Studies of Cardiovascular Disease in European and Non-European Populations , 2014, Current Genetic Medicine Reports.

[24]  David R. O'Brien,et al.  Cell Type-Specific Expression Analysis to Identify Putative Cellular Mechanisms for Neurogenetic Disorders , 2014, The Journal of Neuroscience.

[25]  Adam J. Schwarz,et al.  CNVs conferring risk of autism or schizophrenia affect cognition in controls , 2013, Nature.

[26]  Lars Feuk,et al.  The Database of Genomic Variants: a curated collection of structural variation in the human genome , 2013, Nucleic Acids Res..

[27]  S. Horvath,et al.  Integrative Functional Genomic Analyses Implicate Specific Molecular Pathways and Circuits in Autism , 2013, Cell.

[28]  Wei Niu,et al.  Coexpression Networks Implicate Human Midfetal Deep Cortical Projection Neurons in the Pathogenesis of Autism , 2013, Cell.

[29]  Stephan J Sanders,et al.  Adjusting Head Circumference for Covariates in Autism: Clinical Correlates of a Highly Heritable Continuous Trait , 2013, Biological Psychiatry.

[30]  Niklas Krumm,et al.  Transmission disequilibrium of small CNVs in simplex autism. , 2013, American journal of human genetics.

[31]  D. Goldstein,et al.  Genic Intolerance to Functional Variation and the Interpretation of Personal Genomes , 2013, PLoS genetics.

[32]  Kathryn Roeder,et al.  Integrated Model of De Novo and Inherited Genetic Variants Yields Greater Power to Identify Risk Genes , 2013, PLoS genetics.

[33]  David W. Evans,et al.  Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidence , 2013, The Lancet Neurology.

[34]  Kathryn Roeder,et al.  Analysis of Rare, Exonic Variation amongst Subjects with Autism Spectrum Disorders and Population Controls , 2013, PLoS genetics.

[35]  D H Geschwind,et al.  Using large clinical data sets to infer pathogenicity for rare copy number variants in autism cohorts , 2012, Molecular Psychiatry.

[36]  Robert A Harris,et al.  Mutations in BCKD-kinase Lead to a Potentially Treatable Form of Autism with Epilepsy , 2012, Science.

[37]  Toshiro K. Ohsumi,et al.  Sequencing Chromosomal Abnormalities Reveals Neurodevelopmental Loci that Confer Risk across Diagnostic Boundaries , 2012, Cell.

[38]  Kenny Q. Ye,et al.  De Novo Gene Disruptions in Children on the Autistic Spectrum , 2012, Neuron.

[39]  Michael F. Walker,et al.  De novo mutations revealed by whole-exome sequencing are strongly associated with autism , 2012, Nature.

[40]  Evan T. Geller,et al.  Patterns and rates of exonic de novo mutations in autism spectrum disorders , 2012, Nature.

[41]  Bradley P. Coe,et al.  Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations , 2012, Nature.

[42]  D. Licatalosi,et al.  FMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism , 2011, Cell.

[43]  Boris Yamrom,et al.  Rare De Novo and Transmitted Copy-Number Variation in Autistic Spectrum Disorders , 2011, Neuron.

[44]  Kathryn Roeder,et al.  Multiple Recurrent De Novo CNVs, Including Duplications of the 7q11.23 Williams Syndrome Region, Are Strongly Associated with Autism , 2011, Neuron.

[45]  M. Daly,et al.  Proteins Encoded in Genomic Regions Associated with Immune-Mediated Disease Physically Interact and Suggest Underlying Biology , 2011, PLoS genetics.

[46]  Deborah A Nickerson,et al.  De novo rates and selection of large copy number variation. , 2010, Genome research.

[47]  C. Lord,et al.  The Simons Simplex Collection: A Resource for Identification of Autism Genetic Risk Factors , 2010, Neuron.

[48]  Gary D Bader,et al.  Functional impact of global rare copy number variation in autism spectrum disorders , 2010, Nature.

[49]  Ute Moog,et al.  Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation , 2010, Nature Genetics.

[50]  John A. Sweeney,et al.  Genome-Wide Analyses of Exonic Copy Number Variants in a Family-Based Study Point to Novel Autism Susceptibility Genes , 2009, PLoS genetics.

[51]  C. Baker,et al.  Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. , 2008, The New England journal of medicine.

[52]  Joshua M. Korn,et al.  Association between microdeletion and microduplication at 16p11.2 and autism. , 2008, The New England journal of medicine.

[53]  D. Pinto,et al.  Structural variation of chromosomes in autism spectrum disorder. , 2008, American journal of human genetics.

[54]  D. Conrad,et al.  Recurrent 16p11.2 microdeletions in autism. , 2007, Human molecular genetics.

[55]  Joseph T. Glessner,et al.  PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. , 2007, Genome research.

[56]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[57]  Kenny Q. Ye,et al.  Strong Association of De Novo Copy Number Mutations with Autism , 2007, Science.

[58]  C. Yau,et al.  QuantiSNP: an Objective Bayes Hidden-Markov Model to detect and accurately map copy number variation using SNP genotyping data , 2007, Nucleic acids research.

[59]  Thomas Bourgeron,et al.  Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders , 2007, Nature Genetics.

[60]  E. Li,et al.  Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting , 2004, Nature.

[61]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[62]  Bertrand Fontaine,et al.  Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia , 1999, Nature Genetics.

[63]  Daniel Davies,et al.  Plink , 1998, The Lancet.

[64]  Ping Fang,et al.  De novo truncating mutations in E6-AP ubiquitin-protein ligase gene (UBE3A) in Angelman syndrome , 1997, Nature Genetics.

[65]  Patricia Spallone,et al.  Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome , 1993, Nature Genetics.

[66]  R. Schmickel.  Contiguous gene syndromes: a component of recognizable syndromes. , 1986, The Journal of pediatrics.

[67]  D. Ledbetter,et al.  Miller-Dieker syndrome: lissencephaly and monosomy 17p. , 1983, The Journal of pediatrics.

[68]  D. Ledbetter,et al.  Deletions of chromosome 15 as a cause of the Prader-Willi syndrome. , 1981, The New England journal of medicine.